Targeted therapy with imatinib: hits and misses?

J Clin Oncol. 2005 Jan 1;23(1):8-10. doi: 10.1200/JCO.2005.09.961. Epub 2004 Nov 15.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Benzamides
  • Gastrointestinal Neoplasms / drug therapy
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Piperazines* / pharmacology
  • Piperazines* / therapeutic use
  • Protein-Tyrosine Kinases / adverse effects*
  • Pyrimidines* / pharmacology
  • Pyrimidines* / therapeutic use

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases